DRW Securities’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 1831 |
|
|
2025
Q4 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 1809 |
|
|
2025
Q3 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 1688 |
|
|
2025
Q2 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 1300 |
|
|
2025
Q1 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 857 |
|
|
2024
Q4 | $0 | Hold |
40,000
| – | – | ﹤0.01% | 823 |
|
|
2024
Q3 | $80.4K | Hold |
40,000
| – | – | ﹤0.01% | 537 |
|
|
2024
Q2 | $66.4K | Hold |
40,000
| – | – | ﹤0.01% | 499 |
|
|
2024
Q1 | $242K | Hold |
40,000
| – | – | 0.01% | 310 |
|
|
2023
Q4 | $281K | Hold |
40,000
| – | – | ﹤0.01% | 246 |
|
|
2023
Q3 | $350K | Hold |
40,000
| – | – | 0.01% | 252 |
|
|
2023
Q2 | $470K | Hold |
40,000
| – | – | 0.01% | 213 |
|
|
2023
Q1 | $685K | Hold |
40,000
| – | – | 0.01% | 174 |
|
|
2022
Q4 | $1.05M | Hold |
40,000
| – | – | 0.03% | 113 |
|
|
2022
Q3 | $4.06M | Hold |
40,000
| – | – | 0.09% | 69 |
|
|
2022
Q2 | $5.65M | Hold |
40,000
| – | – | 0.14% | 48 |
|
|
2022
Q1 | $6.31M | Hold |
40,000
| – | – | 0.17% | 47 |
|
|
2021
Q4 | $8.87M | Hold |
40,000
| – | – | 0.25% | 33 |
|
|
2021
Q3 | $7.72M | Hold |
40,000
| – | – | 0.34% | 30 |
|
|
2021
Q2 | $9.61M | Buy |
40,000
+19,464
| +95% | +$5.34M | 0.3% | 29 |
|
|
2021
Q1 | $6.97M | Buy |
+20,536
| New | +$8.35M | 0.28% | 26 |
|
|
2020
Q4 | – | Sell |
-580
| Closed | -$268K | – | 209 |
|
|
2020
Q3 | $268K | Buy |
+580
| New | +$164K | 0.01% | 129 |
|
DRW Securities's TFFP Position: Q1 2026 in Review
DRW Securities held its TFF Pharmaceuticals, Inc. Common Stock (TFFP) position steady in Q1 2026 at 40,000 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1831.
DRW Securities first reported a position in TFFP in Q3 2020 and has held it in 22 quarters since. The position peaked at $9.61M in Q2 2021. 1 fund tracked by Wall St. Rank holds TFFP as of Q1 2026.
- DRW Securities held 40,000 shares of TFF Pharmaceuticals, Inc. Common Stock worth $0 as of Q1 2026.
- DRW Securities left its TFF Pharmaceuticals, Inc. Common Stock share count unchanged in Q1 2026.
- TFF Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of DRW Securities's portfolio in Q1 2026, its #1831 holding.
- DRW Securities first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and has held it in 22 quarters since.
- DRW Securities's TFF Pharmaceuticals, Inc. Common Stock position peaked at $9.61M in Q2 2021.
- 1 fund tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q1 2026.
Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.